Susquehanna International Group, LLP Vigil Neuroscience, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 212,664 shares of VIGL stock, worth $644,371. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,664Holding current value
$644,371% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
26.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$17.7 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$12.8 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$6.03 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$5.5 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.51MShares$4.57 Million0.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $85.7M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...